I'm driven to unravel AAV immunogenicity for rare disease gene therapies, translating complex immunology into life-changing treatments. I thrive in collaborative environments, pushing the boundaries of scientific discovery.
At a glance
Curated signals on strengths, focus areas, and how they can help.
Led AAV immunology initiatives as Associate Director at Solid Biosciences.
Specializes in unraveling AAV immunogenicity for rare disease gene therapies.
Can help others by providing expertise in AAV immunogenicity for gene therapy.
🚀 Career trajectory
Postdoctoral Research
Conducted foundational research as a Postdoctoral Fellow at the Broad Institute, focusing on molecular and cellular biology.
✦ Molecular Biology
✦ Cell Biology
✦ Research
Scientific Advancement
Progressed through Scientist roles at Homology Medicines, gaining hands-on experience in gene therapy and molecular techniques.
✦ Assay Development
✦ Drug Development
✦ Immunology
Leadership in Gene Therapy
Currently driving AAV immunology initiatives as Associate Director at Solid Biosciences, focusing on rare diseases.
✦ AAV Gene Therapy
✦ Immunogenicity
✦ Associate Director
💪🏻 Superpowers
Pioneering Gene Therapy Immunogenicity
Deep expertise in understanding and mitigating immune responses to AAV vectors.
✦ Specializing in AAV immunogenicity to enable effective gene therapy delivery.
✦ Developing strategies to overcome immune barriers in rare disease treatments.
✦ Leveraging cross-functional leadership in complex drug development.
Translational Immunology Expert
Bridging pre-clinical research with clinical strategy for rare diseases.
✦ Proven track record in pre-clinical studies and assay development.
✦ Translating complex immunological data into actionable clinical strategies.
✦ Focus on patient safety and therapeutic efficacy in gene therapy.
Strategic Program Leadership
Driving drug development programs from concept to clinical advancement.
✦ Expertise in program leadership and strategic planning for novel therapeutics.
✦ Managing cross-functional teams to achieve critical development milestones.
✦ Experience in rare diseases and advanced therapeutic modalities.
I'm excited about
✦ Exploring new collaborations to accelerate AAV gene therapy development.
✦ Seeking opportunities to contribute to innovative rare disease treatments.
✦ Connecting with leaders in the gene therapy and immunology space.
I can help with
✦ Providing expertise in AAV immunogenicity and its impact on gene therapy efficacy.
✦ Sharing insights on strategic planning for pre-clinical and clinical development.
✦ Facilitating cross-functional understanding in complex therapeutic programs.
I would love your help on
✦ Connecting with KOLs in rare disease patient advocacy.
✦ Identifying potential partners for novel immunomodulatory approaches.
✦ Gaining insights into emerging technologies in gene delivery systems.